A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial

M.R. Mirza, L. Bjørge, F. Marmé, R. DePont Christensen, M. Gil-Martin, A. Auranen, B. Ataseven, M.J. Rubio, V. Salutari, B. Lund, I. Runnebaum, A. Redondo, K. Lindemann, F. Trillsch, M.P. Barretina Ginesta, H. Roed, J. Løhndorf, G-B. Nyvang, J. Sehouli

Research output: Contribution to journalConference abstract in journalpeer-review

Original languageEnglish
Article numberLBA28
JournalAnnals of Oncology
Volume31
Issue numberSuppl. 4
Pages (from-to)S1160
ISSN0923-7534
DOIs
Publication statusPublished - 2020
EventESMO Virtual Congress 2020 - Virtual
Duration: 19 Sep 202021 Sep 2020
https://www.esmo.org/meetings/past-meetings/esmo-virtual-congress-2020

Conference

ConferenceESMO Virtual Congress 2020
LocationVirtual
Period19/09/202021/09/2020
Internet address

Bibliographical note

Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020

Cite this